[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2017-2022 United States Onychomycosis (Tinea Unguium) Drug Market Report (Status and Outlook)

November 2017 | 118 pages | ID: 25198A05915EN
LP Information

US$ 3,360.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In 2016, the Onychomycosis (Tinea Unguium) Drug market size was xx million USD in United States, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022.

In United States market, the top players include
  • Johnson & Johnson
  • GSK
  • Novartis
  • Pfizer
  • Valeant Pharma
  • Kaken Pharmaceutical
  • Galderma
  • Xiuzheng Pharmaceutical
  • Letai
  • Qilu Pharmaceutical
Split by product types/category, covering
  • Oral
  • External
Split by applications/end use industries, covers
  • Age under 18
  • Age 18-50
  • Age above 50
1 ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Onychomycosis (Tinea Unguium) Drug
1.2 Onychomycosis (Tinea Unguium) Drug Market Segment by Types
  1.2.1 United States Onychomycosis (Tinea Unguium) Drug Sales Present Situation and Outlook by Types (2012-2022)
  1.2.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Types in 2016
  1.2.3 Oral
    1.2.3.1 Major Players of Oral
  1.2.4 External
    1.2.4.1 Major Players of External
1.3 United States Onychomycosis (Tinea Unguium) Drug Market Segment by Applications/End Use Industries
  1.3.1 United States Onychomycosis (Tinea Unguium) Drug Sales Present Situation and Outlook by Applications/End Industrials (2012-2022)
  1.3.2 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Applications in 2016
  1.3.2 Age under
  1.3.3 Age 18-50
  1.3.4 Age above
1.4 United States Onychomycosis (Tinea Unguium) Drug Overview and Market Size (Value) (2012-2022)
  1.4.1 United States Market Onychomycosis (Tinea Unguium) Drug Overview
  1.4.2 United States Onychomycosis (Tinea Unguium) Drug Market Size (Value and Volume) Status and Forecast (2012-2022)

2 UNITED STATES ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG SALES, REVENUE (VALUE) AND MARKET SHARE BY PLAYERS

2.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share (2012-2017) by Players
2.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Players (2012-2017)
2.3 United States Onychomycosis (Tinea Unguium) Drug Average Price by Players in 2016
2.4 United States Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
2.5 Onychomycosis (Tinea Unguium) Drug Market Competitive Situation and Trends
  2.5.1 Onychomycosis (Tinea Unguium) Drug Market Concentration Rate
  2.5.2 Onychomycosis (Tinea Unguium) Drug Market Share of Top 3 and Top 5 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG SALES, REVENUE (VALUE) BY TYPE AND APPLICATION (2012-2017)

3.1 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Market Share and Price by Type (2012-2017)
  3.1.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Type (2012-2017)
  3.1.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2012-2017)
  3.1.3 United States Onychomycosis (Tinea Unguium) Drug Price by Type (2012-2017)
3.2 United States Onychomycosis (Tinea Unguium) Drug Sales and Market Share by Application (2012-2017)
3.3 United States Market Onychomycosis (Tinea Unguium) Drug Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)

4 UNITED STATES ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG PLAYERS PROFILES AND SALES DATA

4.1 Johnson & Johnson
  4.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.1.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.1.2.1 Type
    4.1.2.2 Type
  4.1.3 Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.1.4 Main Business/Business Overview
  4.1.5 Johnson & Johnson News
4.2 GSK
  4.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.2.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.2.2.1 Type
    4.2.2.2 Type
  4.2.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.2.4 Main Business/Business Overview
  4.2.5 GSK News
4.3 Novartis
  4.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.3.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.3.2.1 Type
    4.3.2.2 Type
  4.3.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.3.4 Main Business/Business Overview
  4.3.5 Novartis News
4.4 Pfizer
  4.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.4.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.4.2.1 Type
    4.4.2.2 Type
  4.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.4.4 Main Business/Business Overview
  4.4.5 Pfizer News
4.5 Valeant Pharma
  4.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.5.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.5.2.1 Type
    4.5.2.2 Type
  4.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.5.4 Main Business/Business Overview
  4.5.5 Valeant Pharma News
4.6 Kaken Pharmaceutical
  4.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.6.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.6.2.1 Type
    4.6.2.2 Type
  4.6.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.6.4 Main Business/Business Overview
  4.6.5 Kaken Pharmaceutical News
4.7 Galderma
  4.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.7.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.7.2.1 Type
    4.7.2.2 Type
  4.7.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.7.4 Main Business/Business Overview
  4.7.5 Galderma News
4.8 Xiuzheng Pharmaceutical
  4.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.8.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.8.2.1 Type
    4.8.2.2 Type
  4.8.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.8.4 Main Business/Business Overview
  4.8.5 Xiuzheng Pharmaceutical News
4.9 Letai
  4.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.9.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    9.9.2.1 Type
    9.9.2.2 Type
  4.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.9.4 Main Business/Business Overview
  4.9.5 Letai News
4.10 Qilu Pharmaceutical
  4.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  4.10.2 Onychomycosis (Tinea Unguium) Drug Product Types, Application and Specification
    4.10.2.1 Type
    4.10.2.2 Type
  4.10.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
  4.10.4 Main Business/Business Overview
  4.10.5 Qilu Pharmaceutical News

5 UNITED STATES ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG MARKET FORECAST (2017-2022)

5.1 United States Onychomycosis (Tinea Unguium) Drug Sales, Revenue and Price Forecast (2017-2022)
  5.1.1 United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2017-2022)
  5.1.2 United States Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast (2017-2022)
  5.1.3 United States Onychomycosis (Tinea Unguium) Drug Price Trend Forecast (2017-2022)
5.2 United States Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2017-2022)
5.3 United States Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2017-2022)

6 PRODUCTION COST ANALYSIS OF ONYCHOMYCOSIS (TINEA UNGUIUM) DRUG

6.1 Main Raw Materials of Onychomycosis (Tinea Unguium) Drug
  6.1.1 List of Onychomycosis (Tinea Unguium) Drug Main Raw Materials
  6.1.2 Onychomycosis (Tinea Unguium) Drug Main Raw Materials Price Analysis
  6.1.3 Onychomycosis (Tinea Unguium) Drug Raw Materials Major Suppliers
  6.1.4 Onychomycosis (Tinea Unguium) Drug Main Raw Materials Market Concentration Rate
6.2 Production Cost Structure of Onychomycosis (Tinea Unguium) Drug
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Production Expenses
6.3 Onychomycosis (Tinea Unguium) Drug Manufacturing Process/Method

7 VALUE CHAIN, PURCHASING STRATEGY AND DOWNSTREAM BUYERS

7.1 Onychomycosis (Tinea Unguium) Drug Value Chain Analysis
7.2 Upstream Raw Materials Purchasing
7.3 Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Players in 2016
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Sales Channel
  8.1.1 Direct Sales
  8.1.2 Indirect Sales
  8.1.3 Sales Channel Development Trend
8.2 Product Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Onychomycosis (Tinea Unguium) Drug Distributors/Traders List in United States

9 MARKET INFLUENCES FACTORS ANALYSIS

9.1 Changes from the Related Industries
9.2 Substitutes Threat
9.3 Customer Preference Change
9.4 Economic/Political Environmental Change
9.5 Upstream and Downstream Fluctuation

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Data Source
LIST OF TABLES AND FIGURES

Figure Picture of Onychomycosis (Tinea Unguium) Drug
Table Product Specifications of Onychomycosis (Tinea Unguium) Drug
Figure United States Onychomycosis (Tinea Unguium) Drug Sales (volume) for Each Type (2012-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Types in 2016
Table Types of Onychomycosis (Tinea Unguium) Drug
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of External
Table Major Players of External
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Present Situation and Outlook by Applications (2012-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Applications in 2016
Table Applications of Onychomycosis (Tinea Unguium) Drug
Figure Age under 18 Examples
Figure Age 18-50 Examples
Figure Age above 50 Examples
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) Status and Forecast (2012-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales (Volume) Status and Forecast (2012-2022)
Table United States Onychomycosis (Tinea Unguium) Drug Sales by Players (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales Market Share (%) by Players (2012-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Share by Players in 2016
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Share by Players in 2017
Table United States Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Players (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Revenue Market Share (%) by Players (2012-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue Share by Players in 2016
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue Share by Players in 2017
Figure United States Onychomycosis (Tinea Unguium) Drug Average Price by Players in 2016
Table United States Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution and Sales Area by Players
Table Players Onychomycosis (Tinea Unguium) Drug Product Types
Figure Onychomycosis (Tinea Unguium) Drug Market Share of Top 3 Players
Figure Onychomycosis (Tinea Unguium) Drug Market Share of Top 5 Players
Table United States Onychomycosis (Tinea Unguium) Drug Sales by Type (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type (2012-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type 2016
Figure 2016 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Type
Table United States Onychomycosis (Tinea Unguium) Drug Revenue (Million USD) by Type (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type (2012-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type 2016
Figure 2016 United States Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Type
Table United States Onychomycosis (Tinea Unguium) Drug Price by Type (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales by Application (2012-2017)
Table United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application (2012-2017)
Figure 2016 United States Onychomycosis (Tinea Unguium) Drug Sales Market Share by Application
Table United States Market Onychomycosis (Tinea Unguium) Drug Sales, Revenue (Million USD), Price and Gross Margin (2012-2017)
Table Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GSK Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table Valeant Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Valeant Pharma Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table Kaken Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table Galderma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Galderma Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table Xiuzheng Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table Letai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Letai Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Table Qilu Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Share (2012-2017)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales and Growth Rate Forecast (2017-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Revenue and Growth Rate Forecast (2017-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Price Trend Forecast (2017-2022)
Table United States Onychomycosis (Tinea Unguium) Drug Sales Forecast by Type (2017-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type (2017-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Type in 2022
Table United States Onychomycosis (Tinea Unguium) Drug Sales Forecast by Application (2017-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Application (2017-2022)
Figure United States Onychomycosis (Tinea Unguium) Drug Sales Market Share Forecast by Application in 2022
Table Production Base and Market Concentration Rate of Raw Material
Figure Onychomycosis (Tinea Unguium) Drug Main Raw Materials Price Trend
Table Onychomycosis (Tinea Unguium) Drug Raw Materials Major Suppliers List
Figure Production Cost Structure of Onychomycosis (Tinea Unguium) Drug
Figure Onychomycosis (Tinea Unguium) Drug Manufacturing Process/Method
Figure Onychomycosis (Tinea Unguium) Drug Value Chain Analysis
Table Raw Materials Sources of Onychomycosis (Tinea Unguium) Drug Major Players in 2016
Table Major Buyers of Onychomycosis (Tinea Unguium) Drug
Table Onychomycosis (Tinea Unguium) Drug Distributors/Traders List in United States


More Publications